Registration

Chair Opening Address 

There is clear data from well-designed large scale studies of pre-emptive pharmacogenomics using small panel tests that adverse drug reactions can be reduced by this approach in a cost-effective manner. Future programs however need to be more comprehensive and inclusive, and potentially could also deliver other predictive genetic tests like polygenic risk scores and screening for late onset treatable monogenic diseases. What does the current data suggest about the ideal model for delivering such a program?

This panel debate will explore the potential benefits and risks of using genomic data in clinical decision making within the NHS. On the one hand, genomic data can provide doctors with important information about a patient's genetic makeup, which can help to tailor treatment plans and improve patient outcomes. On the other hand, there are concerns about the privacy and security of genomic data, as well as the potential for discrimination based on genetic information. The panel will discuss these issues and consider the best ways to balance the benefits and risks of using genomics in clinical care.

• Videha Sharma, NHS Clinician and Lecturer in Health Informatics, University of Manchester (Confirmed)
• Prof. Matt Brown, Chief Scientific Officer, Genomics England (Confirmed)
• Dharmisha Chauhan, Lead Pharmacist – North Thames GMSA, North Thames Genomic Medicine Service Alliance. (Confirmed)

Case Study - Chronomics

Epigenetic data is able to capture the impact of genetic and environmental factors on complex disease risk. Recent advances in epigenetic biomarkers have highlighted its potential to clinical diagnostics and preventative healthcare. In this talk I will discuss the most immediate applications of epigenetics in the clinical practice and some of the work that Hurdle has done in this space.

Q&A Panel

Morning Break

Chair Morning Reflection

Videha leads the clinical digital strategy for the NHS Progress Programme, which aims to incrementally implement pharmacogenomics in primary care. The is a user-centred project, with direct input from primary care clinicians to better understand the front-line needs and requirements of a pharmacogenomics service. In particular, Videha will share how this method helped architect a standards-based technical infrastructure to ensure scalability. 

The world’s population is increasing at a dramatic rate. Since the turn of the millennium the world population has increased by 33%. This growth is set to continue for the next 80 years. Moreso, the growth is in the over 65 years population with little change predicted to birth rates. By 2100 the life expectancy in the UK is predicted to increase to over 90 years of age.

The healthcare needs of the UK population are already increasing with an increasing percentage of over sixty-fives, whilst the percentage of the population at an employable age is reducing.

Chris will look at the attitudes of the Generation Z and Generation Alpha and ask what we need to be aware of and what we need to do now to ensure we can create a workforce for the future with the skills, incentives, capacity and capability of sustaining and providing high quality services to an increasing population.

The NHS Genomic Medicine Service Alliances is supporting the embedding of genomics into everyday practice. This presentation highlights how nurses and midwives are leading the way in innovations to help patients and families have equitable access to genomic healthcare.

Q&A Panel

Lunch & Networking and Close of day